TickerGuard
Buy Day today: Poor (52) Mixed market breadth · today: Core PCE (August) ≈
TNGX

Tango Therapeutics Inc

Healthcare · Biotechnology · —

24.60$ +0.7% vs. previous close Closing price · As of: Sep 24, 2026

Statements

Balance Sheet

All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.

Tick rows to compare them in a chart (up to 4)

Balance Sheet TNGX
Line item 2019 2020 2021 2022 2023 2024 2025
– +271.7% +141.3% -12.7% -7.8% -21.4% +26.0%
– +364.8% +154.3% -23.8% -7.7% -23.1% +32.8%
– +24.0% +403.0% -58.0% +10.7% +4.7% +61.5%
– +370.8% +155.0% -24.5% -8.0% -23.4% +33.0%
– – +0.0% +0.0% -100.0% – –
– – – +0.0% – – –
– -4.4% -46.2% +78.8% – – –
– +252.4% -7.9% +20.3% -20.1% -21.7% -55.1%
– +58.3% -0.6% +36.5% -17.3% -16.9% -43.2%
– +46.4% +56.7% +17.8% +17.6% +17.9% +11.6%
– +174.8% +75.2% +38.0% -37.5% -42.5% -26.2%
– +388.3% +793.1% -27.6% +1.5% -21.2% +73.5%
– – – – – – –
– +0.0% -29.0% +41.4% +7.7% +15.5% +6.4%

Data as of: September 24, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?